Analyst Ratings for Peregrine Pharmaceuticals (PPHM)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/26/2016 | Roth/MKM » Updated 9/9/2016 |
N/A | Downgrade | Neutral (Buy) |
0.50 (N/A) |
1.07 (0.61) |
-42.99% | Details |
7/16/2015 | Noble Capital » Updated 7/15/2016 |
N/A | New Coverage | Outperform (N/A) |
1.50 (N/A) |
1.31 (0.61) |
-53.44% | Details |